Skip to main content

Technology & AI

Rakovina Therapeutics Inc. Announces 2025 Financial Results and Provides Corporate Update

Source: The Manila Times
Rakovina Therapeutics Inc. Announces 2025 Financial Results and Provides Corporate Update

Rakovina Therapeutics Inc. announced its 2025 financial results and provided a corporate update on its AI-driven cancer therapy pipeline. The company reported cash and equivalents of $8.2 million as of December 31, 2025, and highlighted progress in advancing its next-generation cancer treatment programs. Rakovina continues to focus on leveraging artificial intelligence to develop innovative oncology therapies.

Read Full Article at The Manila Times

Related Articles